Market Intelligence

Access the latest earnings reports, market analysis, hot topics, and individual stock insights

Report Categories

View All

Recent Articles

View All
Hezbollah FibreOptic Drone Tactics Highlight Evolving Asymmetric Threats Defense Sector Implications Where Food WFCF Down 1260 How Low Could It Go 20260515 Asia Markets Stay Under Pressure After TrumpXi Summit Ends The Joint JYNT Holds 820 Direction Awaited 20260515 Brigade Enterprises to Develop Premium Housing Project in Hyderabad with Rs 850 Crore Revenue Potential Mazagon Dock Shipbuilders Evaluates Mega Shipyard in Maharashtra Chairman Says Micron Reaches 1 Trillion Market Cap Milestone Amid AIDriven Memory Shortage Oura Health Files Confidentially for IPO Signaling Growing Smart Ring Market Gokaldas Exports Reports 9 Sequential Revenue Growth in Q4 Amid Global Trade Challenges Treasury Yield Surge Challenges RiskFree Status Opens Bond Market Alternatives KULR Q3 2025 Earnings Deep Losses Miss Estimates Despite Stock Surge CDNL Q1 2026 Earnings EPS Surges Past Estimates Revenue Details Absent Stock Slides APAM Q1 2026 Earnings EPS Misses Consensus as Market Headwinds Persist AJG Q1 2026 Earnings Slight Miss on EPS Highlights Steady Underlying Performance CABA Q1 2026 Earnings NarrowerThanExpected Loss Highlights Progress in Autoimmune Pipeline MSI Q1 2026 Earnings Strong Earnings Beat Amid Solid Operational Execution Zions Bancorporation ZION Edges Higher as Regional Banking Sentiment Stabilizes FIGX Capital Acquisition Corp FIGX Holds Steady at 1022 A Stalemate Between Support and Resistance Cineverse Corp CNVS Slips 2 as Stock Tests Key Support Levels Tiptree Inc TIPT Edges Lower Amid Cautious Trading Key Levels in Focus COOTW Warrants Remain Stagnant at 002 Key Levels and Outlook GSI Technology GSIT Declines 2 as Shares Approach Critical Support Level Gloo Holdings Inc GLOO Slides as Selling Pressure Persists DTE Energy Junior Subordinated Debentures DTW Hold Steady as Interest Rate Uncertainty Lingers Praxis Precision Medicines PRAX Slips 24 as Stock Navigates Key Resistance Zone Design Therapeutics DSGN Edges Lower as Stock Tests Support Near 1060